132例复发性肝细胞癌病例的生存分析  

Analysis on the Survival in 132 Recurrent Cases of Hepatocelluar Carainoma

作　　者：沈柏用[1] 郑民华[1] 李建文[1] 王颖[1] 李宏为[1] O.FARGES J.BELGHITI 

机构地区：[1]上海第二医科大学附属瑞金医院普外科,上海200025 [2]巴黎第七大学附属BEAUJON医院肝胆外,巴黎92118

出　　处：《预防医学情报杂志》2000年第2期103-106,共4页Journal of Preventive Medicine Information

摘　　要：目的　研究肝癌复发后的不同治疗方法带来的预后生存的不同。方法　对 2 71例肝癌切除后复发的 132例患者复发情况进行分析 ,同时比较复发后不同治疗方法的结果。结果　 6 7%的肿瘤复发位于肝内 ,而且其中近一半是局限性复发 ,这些病例经再次肝切除、经肝动脉插管化疗栓塞或经皮无水酒精注射治疗后 ,5年生存率可达 30 %。同时发现肝移植亦不失为一种好的方法。结论　对于复发性肝细胞肝癌积极的外科治疗可获好的疗效。Objective To study the reasonable treatment in the recurrence of hepatocellular carcinoma(HCC.)Methoods 132 recurrent cases of hepatocellular carcinoma were analysized by the following factors (host condition,tumor characteristics and surgical procedures from Jan.1983 to Jan.1997), The different surgical treatments in these patients were compared simultaneously.Results 67% of the recurrence were exclusively intrahepatic and half recurrence were limitited in size and number. The survival rate for 5 years was 30% following treatment of limited intrahepatic recurrence by re hepatectomy,arterial chemoembolization or percutaneous ethanol injection,and liver transplantation is needed to obtain better results.Conclusion An aggressive approach to tumor recurrence is the best way to improve the longterm outcome following resection of HCC.

关 键 词：肝细胞肝癌 复发 治疗 生存分析 

分 类 号：R735.7[医药卫生—肿瘤]